Amatsigroup – a global CDMO (contract development and manufacturing organization) providing services in preclinical and clinical phases of drug development.
With over 250 highly qualified employees and a diversified portfolio of 300 international clients, pharmaceutical laboratories and biotechnology companies, Amatsigroup is the French leader in services for pharmaceutical product development in human and animal health.
Amatsigroup offers a wide range of international services in its four strategic business areas: bioservices (in life studies and bioanalysis); pharmaceutical analysis solutions; formulation development and manufacturing; and packaging & logistics of clinical batches, under GLP and GMP environment (European & US accreditations).
Our services for clinical trial supply:
- packaging and labelling
- GMP storage
- QP release services for clinical trial batches
- worldwide distribution to clinical sites.
Amatsigroup has five operational sites in Europe (Amatsi, AmatsiAvepharm, AmatsiAvogadro, AmatsiDBi, AmatsiSEPS) and one site in the US (Amatsigroup Inc).
Our strengths
- experience on more than 30 investigational medicinal products developed and more than 20 developments of veterinary drug
- focus on the reliability of data from the study design or process for the drafting of European and US registration dossiers
- product development projects under the supervision of our CMC & Regulatory Affairs team.